Subtle Medical Announces Strong 2025 Growth, Expands Market Leadership in AI Imaging
MENLO PARK, Calif., Oct. 1, 2025 /PRNewswire/ — Subtle Medical, a global leader in AI-powered medical imaging, today announced major growth milestones, projecting 2.5x annualized revenue growth in the U.S. for 2025, fueled by strong enterprise demand and new product introductions. Their U.S. adoption now spans more than 600 installations and well over 1000 globally.
Subtle continues to lead the AI imaging enhancement market, with multiple FDA-cleared solutions and the broadest install base among competitors. Its flagship SubtleHD™ software and newly launched Subtle-ELITE™ suite are enabling health systems to accelerate scans, improve image quality, and optimize workflow efficiency.
Last week, TIME recognized Subtle Medical on its list of the World’s Top HealthTech Companies of 2025, highlighting the company’s impact in AI and data-driven innovation for imaging. Leading providers are deepening their enterprise-level partnerships with Subtle, citing measurable ROI and improved patient care.
